Technologies developed through the Medical University of South Carolina in Charleston obtained a record 69 patents in fiscal year 2015.
The MUSC Foundation of Research Development said Wednesday that the bulk of those were issued overseas. Seventeen were issued in the United States.
It was the most in the organization’s 15-year history.
Companies with ties to MUSC that obtained patents last fiscal year include SphingoGene Inc., FirstString Research and MicroVide, LLC.
“To have so many technologies successfully go through such rigorous review, both domestically and abroad, speaks to the novelty of the technologies that are being created at MUSC,” said Jesse Goodwin, the research foundation’s deputy director.
One private company that partners with MUSC — Alexion Pharmaceuticals — was responsible for 38 of the issues, “due in large part to one therapy that was patented in 32 European countries,” according to a written statement.
The foundation helps commercialize research developed at MUSC. Its previous annual record for patents came in fiscal 2014, when it obtained 33. Fifty startup companies have come out of the foundation.
Reach Allison Prang at 937-5705 or follow her on Twitter @AllisonPrang.